FR2100742A1 - - Google Patents

Info

Publication number
FR2100742A1
FR2100742A1 FR7120861A FR7120861A FR2100742A1 FR 2100742 A1 FR2100742 A1 FR 2100742A1 FR 7120861 A FR7120861 A FR 7120861A FR 7120861 A FR7120861 A FR 7120861A FR 2100742 A1 FR2100742 A1 FR 2100742A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7120861A
Other languages
French (fr)
Other versions
FR2100742B1 (da
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2100742A1 publication Critical patent/FR2100742A1/fr
Application granted granted Critical
Publication of FR2100742B1 publication Critical patent/FR2100742B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
FR7120861A 1970-06-10 1971-06-09 Expired FR2100742B1 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4524470A 1970-06-10 1970-06-10

Publications (2)

Publication Number Publication Date
FR2100742A1 true FR2100742A1 (da) 1972-03-24
FR2100742B1 FR2100742B1 (da) 1974-09-06

Family

ID=21936793

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7120861A Expired FR2100742B1 (da) 1970-06-10 1971-06-09

Country Status (8)

Country Link
US (1) US3632778A (da)
BE (1) BE768269A (da)
DE (1) DE2128461A1 (da)
DK (1) DK126236B (da)
ES (1) ES392066A1 (da)
FR (1) FR2100742B1 (da)
GB (1) GB1296505A (da)
NL (1) NL7107643A (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
US4017636A (en) * 1973-10-23 1977-04-12 Abbott Laboratories Esters of γ-glutamyl amide of dopamine
US4209513A (en) * 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
DE2513940A1 (de) * 1975-03-29 1976-10-14 Merck Patent Gmbh Pharmazeutische zubereitung
US4097606A (en) * 1975-10-08 1978-06-27 Bristol-Myers Company APAP Tablet containing an alkali metal carboxymethylated starch and processes for manufacturing same
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
DE2551446B2 (de) * 1975-11-15 1977-09-15 Karl Werner Schlüter GmbH, 2000 Ham burg Verfahren zur herstellung von suppositorien
JPS5332111A (en) * 1976-09-07 1978-03-27 Asahi Chem Ind Co Ltd Composition for tablet
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
US4195078A (en) * 1979-03-09 1980-03-25 Eli Lilly And Company Nabilone granulation
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4327080A (en) * 1981-07-13 1982-04-27 E. R. Squibb & Sons, Inc. Novel Bendroflumethiazide formulations and method
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4736527A (en) * 1982-12-13 1988-04-12 Konishiroku Photo Industry Co., Ltd. Apparatus for the heat treatment of powdery material
ES2040733T3 (es) * 1986-12-20 1993-11-01 Boehringer Mannheim Gmbh Medicamentos que contienen clodronato y procedimiento para su preparacion.
HU209564B (en) * 1991-01-30 1994-07-28 Egyt Gyogyszervegyeszeti Gyar Process for producing rapide tablets containing levodopa and carbidopa
DK3148513T3 (da) * 2014-05-29 2020-05-25 Novartis Ag Ceritinib-formulering

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
FR1588801A (da) * 1967-04-07 1970-03-16
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
FR1588801A (da) * 1967-04-07 1970-03-16
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine

Also Published As

Publication number Publication date
US3632778A (en) 1972-01-04
DE2128461A1 (de) 1971-12-16
ES392066A1 (es) 1974-10-16
FR2100742B1 (da) 1974-09-06
NL7107643A (da) 1971-12-14
DK126236B (da) 1973-06-25
BE768269A (fr) 1971-12-09
GB1296505A (da) 1972-11-15

Similar Documents

Publication Publication Date Title
AR204384A1 (da)
FR2100742B1 (da)
AU2044470A (da)
AU1716970A (da)
AU1517670A (da)
AU1833270A (da)
AU2017870A (da)
AU2085370A (da)
AU2130570A (da)
AR195465A1 (da)
AU2115870A (da)
AU1832970A (da)
AU1581370A (da)
AU1591370A (da)
AU1603270A (da)
AU1689770A (da)
AU1235770A (da)
AU2144270A (da)
AU2131570A (da)
AU2130770A (da)
AU1789870A (da)
AU2119370A (da)
AU1277070A (da)
AU2112570A (da)
AU1841070A (da)

Legal Events

Date Code Title Description
ST Notification of lapse